HIT PE Ratio & Valuation, Is HIT Overvalued

Historical Valuation

Health In Tech Inc (HIT) is now in the Fair zone, suggesting that its current forward PE ratio of 31.82 is considered Fairly compared with the five-year average of 22.36. The fair price of Health In Tech Inc (HIT) is between 0.44 to 1.99 according to relative valuation method.

Relative Value

Fair Zone

0.44-1.99

Current Price：1.90

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Health In Tech Inc (HIT) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Health In Tech Inc (HIT) has a current Price-to-Book (P/B) ratio of 5.76. Compared to its 3-year average P/B ratio of 10.97, the current P/B ratio is approximately -47.50% higher. Relative to its 5-year average P/B ratio of 10.97, the current P/B ratio is about -47.50% higher. Health In Tech Inc (HIT) has a Forward Free Cash Flow (FCF) yield of approximately 2.16%. Compared to its 3-year average FCF yield of 4.18%, the current FCF yield is approximately -48.31% lower. Relative to its 5-year average FCF yield of 4.18%, the current FCF yield is about -48.31% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for HIT competitors is 2.13, providing a benchmark for relative valuation. Health In Tech Inc Corp (HIT.O) exhibits a P/S ratio of 2.56, which is 20.62% above the industry average. Given its robust revenue growth of 90.41%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of HIT increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of HIT in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is HIT currently overvalued or undervalued?

What is Health In Tech Inc (HIT) fair value?

HIT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Health In Tech Inc (HIT) is between 0.44 to 1.99 according to relative valuation method.

How does HIT's valuation metrics compare to the industry average?

The average P/S ratio for HIT's competitors is 2.13, providing a benchmark for relative valuation. Health In Tech Inc Corp (HIT) exhibits a P/S ratio of 2.56, which is 20.62% above the industry average. Given its robust revenue growth of 90.41%, this premium appears sustainable.

What is the current P/B ratio for Health In Tech Inc (HIT) as of Mar 11 2026?

As of Mar 11 2026, Health In Tech Inc (HIT) has a P/B ratio of 5.76. This indicates that the market values HIT at 5.76 times its book value.

What is the current FCF Yield for Health In Tech Inc (HIT) as of Mar 11 2026?

As of Mar 11 2026, Health In Tech Inc (HIT) has a FCF Yield of 2.16%. This means that for every dollar of Health In Tech Inc's market capitalization, the company generates 2.16 cents in free cash flow.

What is the current Forward P/E ratio for Health In Tech Inc (HIT) as of Mar 11 2026?

As of Mar 11 2026, Health In Tech Inc (HIT) has a Forward P/E ratio of 31.82. This means the market is willing to pay $31.82 for every dollar of Health In Tech Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Health In Tech Inc (HIT) as of Mar 11 2026?

As of Mar 11 2026, Health In Tech Inc (HIT) has a Forward P/S ratio of 2.56. This means the market is valuing HIT at $2.56 for every dollar of expected revenue over the next 12 months.

HIT Valuation